Feb 12 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2015 Dec 31, 2014 Dec 31, 2016 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 37 mln 26 mln 29 mln 14 mln
(+43.1 pct) (-61.7 pct) (-20.3 pct) (-1.4 pct)
Operating loss 999 mln loss 1.00 loss 2.12 loss 1.08
Recurring loss 990 mln loss 1.01 loss 2.10 loss 1.07
Net loss 878 mln loss 1.02 loss 2.08 loss 1.04
EPS loss 131.21 yen loss 151.96 yen loss 262.92 yen loss 138.25 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Medrx.Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T
((Tokyo Headline News Desk +813 6441 1812))